Multicancer early detection tests: where are we?
作者信息
Loomans-Kropp Holli A
机构信息
Divison of Cancer Prevention and Control, Department of Internal Medicine, College of Medicine, The Ohio State University, Columbus, OH, USA.
出版信息
JNCI Cancer Spectr. 2023 Jan 3;7(1). doi: 10.1093/jncics/pkac084.
Abstract
摘要
相似文献
1
Multicancer early detection tests: where are we?多癌早期检测测试：我们目前处于什么阶段？
JNCI Cancer Spectr. 2023 Jan 3;7(1). doi: 10.1093/jncics/pkac084.
2
Further Discussion Regarding Multicancer Early Detection Tests.关于多癌早期检测测试的进一步讨论
Am Fam Physician. 2024 Feb;109(2):104.
3
Considerations in the implementation of multicancer early detection tests.多癌早期检测测试实施中的注意事项。
Future Oncol. 2022 Sep;18(28):3119-3124. doi: 10.2217/fon-2022-0120. Epub 2022 Sep 5.
4
Multicancer Early Detection.多癌早期检测
Clin Gastroenterol Hepatol. 2023 Dec;21(13):3464. doi: 10.1016/j.cgh.2023.03.039. Epub 2023 Apr 7.
5
The Promise of Multicancer Early Detection.多癌早期检测的前景
Am J Med. 2023 Mar;136(3):e46-e47. doi: 10.1016/j.amjmed.2022.05.016.
6
Novel multicancer early detection technology-potential value to employers and the workforce.新型多癌早期检测技术——对雇主和员工的潜在价值。
Am J Manag Care. 2020 Dec;26(10 Spec No.):SP363. doi: 10.37765/ajmc.2020.88567.
7
Multicancer Early Detection: Learning From the Past to Meet the Future.多癌种早期检测：从过去中学习，以应对未来。
J Natl Cancer Inst. 2022 Mar 8;114(3):349-352. doi: 10.1093/jnci/djab168.
8
The Promise of Multicancer Early Detection. Comment on Pons-Belda et al. Can Circulating Tumor DNA Support a Successful Screening Test for Early Cancer Detection? The Grail Paradigm. 2021, , 2171.多癌早期检测的前景。对庞斯 - 贝尔达等人的评论。循环肿瘤DNA能否支持早期癌症检测的成功筛查测试？圣杯范式。2021年，，2171。 （注：原文中存在一些格式不规范和不完整的地方，可能会影响准确理解。）
Diagnostics (Basel). 2022 May 17;12(5):1243. doi: 10.3390/diagnostics12051243.
9
Examining developments in multicancer early detection: highlights of new clinical data from recent conferences.探讨多癌种早期检测的新进展：近期会议中新型临床数据要点。
Am J Manag Care. 2021 Dec;27(19 Suppl):S347-S355. doi: 10.37765/ajmc.2021.88801.
10
Multicancer Early Detection: A Promise Yet to Be Proven.多癌早期检测：有待证实的承诺。
Am Fam Physician. 2023 Mar;107(3):224-225A.
引用本文的文献
1
Perceptions of Multicancer Detection Tests Among Primary Care Physicians and Laypersons: A Qualitative Study.多癌种早期检测筛查在初级保健医生和非医学专业人士中的认知：一项定性研究。
Cancer Med. 2024 Nov;13(21):e70281. doi: 10.1002/cam4.70281.
2
Perspectives on Clinical Adoption Barriers to Blood-Based Multi-Cancer Early Detection Tests across Stakeholders.各利益相关者对基于血液的多癌早期检测测试临床应用障碍的看法。
J Pers Med. 2024 Jun 1;14(6):593. doi: 10.3390/jpm14060593.
3
New regulatory thinking is needed for AI-based personalised drug and cell therapies in precision oncology.在精准肿瘤学中，基于人工智能的个性化药物和细胞疗法需要新的监管思路。
NPJ Precis Oncol. 2024 Jan 30;8(1):23. doi: 10.1038/s41698-024-00517-w.
4
Primary Care Provider Receptivity to Multi-Cancer Early Detection Test Use in Cancer Screening.初级保健提供者对在癌症筛查中使用多癌早期检测测试的接受度。
J Pers Med. 2023 Nov 29;13(12):1673. doi: 10.3390/jpm13121673.
本文引用的文献
1
Prediction of tissue-of-origin of early stage cancers using serum miRNomes.基于血清 microRNA 组学预测早期癌症的组织起源。
JNCI Cancer Spectr. 2023 Jan 3;7(1). doi: 10.1093/jncics/pkac080.
2
Cell-Free DNA-Based Multi-Cancer Early Detection Test in an Asymptomatic Screening Population (NHS-Galleri): Design of a Pragmatic, Prospective Randomised Controlled Trial.基于游离DNA的无症状筛查人群多癌早期检测试验（NHS-Galleri）：一项实用、前瞻性随机对照试验的设计
Cancers (Basel). 2022 Oct 1;14(19):4818. doi: 10.3390/cancers14194818.
3
Considerations in the implementation of multicancer early detection tests.多癌早期检测测试实施中的注意事项。
Future Oncol. 2022 Sep;18(28):3119-3124. doi: 10.2217/fon-2022-0120. Epub 2022 Sep 5.
4
A blood-based miRNA signature with prognostic value for overall survival in advanced stage non-small cell lung cancer treated with immunotherapy.一种基于血液的微小RNA特征对接受免疫治疗的晚期非小细胞肺癌总生存期具有预后价值。
NPJ Precis Oncol. 2022 Mar 31;6(1):19. doi: 10.1038/s41698-022-00262-y.
5
A Novel Blood-Based microRNA Diagnostic Model with High Accuracy for Multi-Cancer Early Detection.一种用于多种癌症早期检测的高精度新型血液微小RNA诊断模型。
Cancers (Basel). 2022 Mar 11;14(6):1450. doi: 10.3390/cancers14061450.
6
Clinical validation of a targeted methylation-based multi-cancer early detection test using an independent validation set.使用独立验证集对靶向甲基化的多癌种早期检测测试进行临床验证。
Ann Oncol. 2021 Sep;32(9):1167-1177. doi: 10.1016/j.annonc.2021.05.806. Epub 2021 Jun 24.
7
ACG Clinical Guidelines: Colorectal Cancer Screening 2021.ACG 临床指南：结直肠癌筛查 2021 年版。
Am J Gastroenterol. 2021 Mar 1;116(3):458-479. doi: 10.14309/ajg.0000000000001122.
8
Association Between Time to Colonoscopy After Positive Fecal Testing and Colorectal Cancer Outcomes: A Systematic Review.粪便检测阳性后行结肠镜检查的时间与结直肠癌结局的关系：系统评价。
Clin Gastroenterol Hepatol. 2021 Jul;19(7):1344-1354.e8. doi: 10.1016/j.cgh.2020.09.048. Epub 2020 Oct 1.
9
Development of a serum miRNA panel for detection of early stage non-small cell lung cancer.用于检测早期非小细胞肺癌的血清 miRNA panel 的开发。
Proc Natl Acad Sci U S A. 2020 Oct 6;117(40):25036-25042. doi: 10.1073/pnas.2006212117. Epub 2020 Sep 17.
10
Non-invasive early detection of cancer four years before conventional diagnosis using a blood test.利用血液检测，可在常规诊断前四年进行非侵入性的癌症早期检测。
Nat Commun. 2020 Jul 21;11(1):3475. doi: 10.1038/s41467-020-17316-z.
Zotero 插件